Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Mitigation of acute lung injury by semaglutide: role of inflammatory and oxidative stress pathways

View through CrossRef
Endotoxic disease Increased production of pro-inflammatory cytokines during bacterial infection is caused by high endotoxin levels, the protective effect of semaglutide on endotoxemia-induced acute lung injury was investigated in this research. twenty-four adult mice of the Swiss-Albano strain, aged 8-14 weeks and weighing between 25- 40 grams, were randomly divided into four groups. The groups were as follows: control (undergoing laparotomy without cecal ligation and puncture), endotoxemia (undergoing cecal ligation and puncture), vehicle (receiving normal saline for 1 week), and treatment (receiving semaglutide at a dose of 0.06mg/kg once daily subcutaneously for 1 week prior to cecal ligation and puncture). The scarification of animals was done 24 hours following the CLP treatment, and their lung tissues were utilized for histological investigation as well as the assessment of inflammatory mediators (IL-6, TNF-α, IL-1B, and NF-KB) and oxidative markers (MDA). The levels of lung tissue, inflammatory mediators, and oxidative stress were considerably elevated (P<0.05) in both the endotoxemia and vehicle groups compared to the control group. The treatment group exhibited significantly reduced levels of inflammatory and oxidative stress mediators compared to the endotoxemia and vehicle groups, with a statistical significance of P<0.05. Microscopically, mice in the endotoxemia and vehicle groups exhibited pronounced lung tissue damage. However, this damage was significantly (P<0.05) mitigated in the group treated with semaglutide. Semaglutide had the capacity to alleviate acute lung damage in male mice exposed to endotoxemia generated by CLP through a decrease in pro-inflammatory cytokines (such as interleukin-1β, interleukin-6, TNF-alpha, and NF-KB) as well as oxidative stress marker (MDA) inside the lung tissue.
Title: Mitigation of acute lung injury by semaglutide: role of inflammatory and oxidative stress pathways
Description:
Endotoxic disease Increased production of pro-inflammatory cytokines during bacterial infection is caused by high endotoxin levels, the protective effect of semaglutide on endotoxemia-induced acute lung injury was investigated in this research.
twenty-four adult mice of the Swiss-Albano strain, aged 8-14 weeks and weighing between 25- 40 grams, were randomly divided into four groups.
The groups were as follows: control (undergoing laparotomy without cecal ligation and puncture), endotoxemia (undergoing cecal ligation and puncture), vehicle (receiving normal saline for 1 week), and treatment (receiving semaglutide at a dose of 0.
06mg/kg once daily subcutaneously for 1 week prior to cecal ligation and puncture).
The scarification of animals was done 24 hours following the CLP treatment, and their lung tissues were utilized for histological investigation as well as the assessment of inflammatory mediators (IL-6, TNF-α, IL-1B, and NF-KB) and oxidative markers (MDA).
The levels of lung tissue, inflammatory mediators, and oxidative stress were considerably elevated (P<0.
05) in both the endotoxemia and vehicle groups compared to the control group.
The treatment group exhibited significantly reduced levels of inflammatory and oxidative stress mediators compared to the endotoxemia and vehicle groups, with a statistical significance of P<0.
05.
Microscopically, mice in the endotoxemia and vehicle groups exhibited pronounced lung tissue damage.
However, this damage was significantly (P<0.
05) mitigated in the group treated with semaglutide.
Semaglutide had the capacity to alleviate acute lung damage in male mice exposed to endotoxemia generated by CLP through a decrease in pro-inflammatory cytokines (such as interleukin-1β, interleukin-6, TNF-alpha, and NF-KB) as well as oxidative stress marker (MDA) inside the lung tissue.

Related Results

Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Safety of Semaglutide
Safety of Semaglutide
The glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutan...
Semaglutide reduces cardiomyocyte damage caused by high-fat through HSDL2
Semaglutide reduces cardiomyocyte damage caused by high-fat through HSDL2
Abstract Background The expression of inflammation and oxidative stress caused by obesity is high, which has a certain degree of damage to myocardial cells. is a glucagon-...
Psychiatric Adverse Events Associated with Semaglutide: A Systematic Review of Evidence and Implications for Clinical Practice
Psychiatric Adverse Events Associated with Semaglutide: A Systematic Review of Evidence and Implications for Clinical Practice
Background: The clinical use of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist authorized for the treatment of type 2 diabetes and obesity, is quickly growing.. Ho...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
&lt;p&gt;&lt;strong&gt;&lt;span dir=&quot;ltr&quot; role=&quot;presentation&quot;&gt;1. Introduction&lt;/span&gt;&lt;/strong&...
Effect of High‑Fat-Diet and Semaglutide on Bladder Cancer in Mice
Effect of High‑Fat-Diet and Semaglutide on Bladder Cancer in Mice
Abstract Objective The aim of this study is to examine the proteomics of adipose tissue in mice with obesity induced by a high-fat diet, in order to investigate how obesity...
Investigating the potential neuroprotective effect of semaglutide in the mouse retina
Investigating the potential neuroprotective effect of semaglutide in the mouse retina
AbstractPurpose: To investigate the potential locally mediated neuroprotective effect of the glucagon‐like peptide 1 receptor agonist, semaglutide, in the mouse retina, including a...
The craze with Semaglutide
The craze with Semaglutide
Semaglutide (Ozempic acid) belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. These medications mimic the action of a hormone called GLP-1, which...

Back to Top